* Enovix Corp reported a quarterly adjusted loss of 31 cents per share for the quarter ended in January, lower than the same quarter last year, when the company reported EPS of -20 cents. The mean expectation of eleven analysts for the quarter was for a loss of 29 cents per share. Wall Street expected results to range from -33 cents to -19 cents per share.
* Revenue rose 25,004.8% to $5.27 million from a year ago; analysts expected $3.78 million.
* Enovix Corp's reported EPS for the quarter was a loss of 28 cents.
* The company reported a quarterly loss of $46.37 million.
* Enovix Corp shares had fallen by 21.8% this quarter and lost 50.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 21.7% in the last three months.
* In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Enovix Corp is $23.00
This summary was machine generated from LSEG data May 1 at 10:40 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.29 -0.31 Missed
Dec. 31 2023 -0.27 -0.28 Missed
Sep. 30 2023 -0.23 -0.19 Beat
Jun. 30 2023 -0.22 -0.19 Beat
Comments